Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
EPRX holding history
Eupraxia Pharmaceuticals Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EPRX overviewAll 13F holders of EPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 17,644
- Value
- $115.2K
- % of portfolio
- <0.1%
- Quarters held
- 1
- Since Q2 2026